Stanford Medcast Episode 4: COVID-19 Mini-series - A Brief Overview of Monoclonal Antibodies

Tuesday, October 13, 2020, 12:00 AM - Thursday, August 31, 2023, 11:59 PM

Listen to Dr. Robert Shafer answer questions on monoclonal antibodies, its use in the treatment of COVID-19 and potential use in the development of a vaccine. 

AMA PRA Category 1 Credits™ (0.25 hours), Non-Physician Participation Credit (0.25 hours)

1. Enumerate the three monoclonal antibodies currently in Phase II and III clinical trials for the treatment of COVID-19.
2. Review the definition of a monoclonal antibody, its use in treating SARS CoV2 infections and consider it’s use when it becomes available for treating COVID-19

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)

Stanford Medicine designates this Enduring Material for a maximum of 0.25 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

References:

1. Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial of ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293–303.

2. Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science 2020May20 (Epub ahead of print)

3. Yu J, Tostanoski LH, Peter L, et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science 2020May20 (Epub ahead of print).

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: [email protected]

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity. 

This CME Activity is supported in part by educational grants from Novartis.